MDK Acquisition, Inc.

As of May 31, 2026, MDK Acquisition, Inc. carries a market capitalization of 310,500.05, placing it among publicly traded companies globally. Its enterprise value stands at 229,913.05, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of May 31, 2026, MDK Acquisition, Inc. has 6.21M shares outstanding.

These figures are as of May 31, 2026.

As of May 31, 2026, MDK Acquisition, Inc. maintains a current ratio of 8.13, meaning it holds 8.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended May 31, 2026, MDK Acquisition, Inc. posted a negative return on equity (ROE) of -69.98, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -57.80, reflecting losses generated across the asset base.

As of the close on October 5, 2026, MDK Acquisition, Inc.'s stock has declined approximately 37.50% over the past 52 weeks.

Over the twelve months ended May 31, 2026, MDK Acquisition, Inc. generated - - in revenue and converted that into -68,953.00 in net income, yielding earnings per share of -0.01. EBITDA reached -71,051.00, while operating income came in at -71,051.00.

These figures are as of May 31, 2026. Total book value stands at 72,075.00, with working capital of 72,075.00 providing operational flexibility.

MDK Acquisition, Inc. produced -52,311.00 in operating cash flow over the twelve months ended May 31, 2026.

These figures cover the twelve months ended May 31, 2026. Free cash flow yield is negative at -16.85: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

As of May 31, 2026, MDK Acquisition, Inc. has an Altman Z-Score of 11.39, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.